retatrutide while breastfeeding What are the considerations for using (glucagon-like peptide-1 receptor agonist) in women with type 2 diabetes or obesity? Can You Take Tirzepatide While

Timing Follow-up Monitoring guidance is trial-informed and incretin-pathway-based because retatrutide is investigational and does not have an approved clinical label

There is no reason to expect Retatrutide would be different

Curr Opin Cardiol

Even their website does not offer enough detail for this type of supplement

Focus on what you can do, when you can do it, and let consistency build gradually

Month 1: 2-4% weight loss, appetite changes beginning Months 2-3: 6-10% cumulative loss, GI symptoms improving Months 4-6: 12-18% cumulative loss, stable dose reached Months 7-9: 18-22% cumulative loss, pace slowing Months 10-12: 20-24% cumulative loss, approaching plateau Plateau typically arrives around month 10-11